Author

Yuting Xu

Institutions: Zhejiang Hospital, Guangzhou Medical University

Observed institutions: Beijing Institute of Technology, Shenzhen University, Nantong University, Affiliated Hospital of Nantong University, Zhejiang Hospital, Shenzhen University Health Science Center, Shenzhen Second People's Hospital, First Affiliated Hospital Zhejiang University, Guangzhou Medical University

ORCID: 0000-0001-6714-7275

Observed ORCID: 0000-0001-6714-7275

OpenAlex ID: A5083609983

The application of HER2 and CD47 CAR-macrophage in ovarian cancer

2023 · Yizhao Chen, Xiangling Zhu, et al. · Journal of Translational Medicine · 94

Synchronously Delivering Melittin and Evoking Ferroptosis via Tumor Microenvironment‐Triggered Self‐Destructive Metal–Organic Frameworks to Boost Cancer Immunotherapy

2025 · Dongsheng Zhang, Tingting Wang, et al. · Advanced Healthcare Materials · 15

Recent Updates on the Role of the MicroRNA-10 Family in Gynecological Malignancies

2022 · Chunhua Li, Xiangling Zhu, et al. · Journal of Oncology · 4

The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer

2024 · Jing Huang, Yuting Xu, et al. · Discover Oncology · 3

Retrieval-Augmented Document-Level Event Extraction with Cross-Attention Fusion

2023 · Yuting Xu, Chong Feng, et al. · Communications in computer and information science · 1

Novel a new prognostic model of thyroid carcinoma based on macrophage and cuproptosis-related lncRNA

2026 · Jiahao Wu, Fan Yang, et al. · Cancer Cell International

Idebenone protects against doxorubicin-induced cardiac injury by inhibiting ferroptosis in cardiomyocytes

2026 · Jie Mao, Zhiyi Zhou, et al. · Experimental Gerontology

Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment

2026 · Rui Wang, Fei Wang, et al. · Cancer Management and Research

Works count: 8

Citation count: 117

H-index: 3

I10-index: 2